I think they will continue to focus on their mission here which is the new class of antibiotics, however this clearly shows we are not a one trick pony and one day we will look forward to massive revenue streams from multiple indications (antiviral, antibiotic IV and antibiotic external for wound healing including burns)
Great announcement in my opinion.
Potential Billion dollar company in the making...!
Ann: Positive Data on RECCE 327 Against Influenza A, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
-0.020(4.49%) |
Mkt cap ! $121.4M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $44.33K | 103.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3902 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 3904 | 1 |
View Market Depth
| Last trade - 15.55pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |